Bolt Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 3.81 M | $2.04 M | 0.00% | 9.97% |
| VIVO CAPITAL, LLC | 02/13/2025 | 3.52 M | $1.88 M | 0.00% | 9.21% |
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 2.75 M | $1.47 M | 0.00% | 7.20% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 02/13/2025 | 1.89 M | $1.02 M | 0.00% | 4.94% |
| NAN FUNG GROUP HOLDINGS LTD | 02/13/2025 | 1.17 M | $624,436 | 0.00% | 3.05% |
| VANGUARD GROUP INC | 02/11/2025 | 1.07 M | $571,062 | 0.00% | 2.79% |
| SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 1.05 M | $561,402 | 0.00% | 2.74% |
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 02/13/2025 | 719,546 | $384,957 | 0.00% | 1.88% |
| PFIZER INC | 02/14/2025 | 626,109 | $335,031 | 100.00% | 1.64% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 340,674 | $182,340 | -3.33% | 0.89% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 302,039 | $161,621 | 2.72% | 0.79% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 270,092 | $144,526 | 0.18% | 0.71% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 244,966 | $131,081 | 0.00% | 0.64% |
| FMR LLC | 02/13/2025 | 129,254 | $69,164 | 12.02% | 0.34% |
| ENGINEERS GATE MANAGER LP | 02/14/2025 | 72,402 | $38,742 | 100.00% | 0.19% |
| UBS GROUP AG | 02/14/2025 | 66,113 | $35,370 | 87.30% | 0.17% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 60,200 | $32,213 | 0.00% | 0.16% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 50,020 | $26,766 | 100.00% | 0.13% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2025 | 50,000 | $26,755 | 100.00% | 0.13% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 48,971 | $26,204 | 100.00% | 0.13% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 47,025 | $25,163 | 100.00% | 0.12% |
| XTX TOPCO LTD | 02/13/2025 | 44,891 | $24,021 | 100.00% | 0.12% |
| JANE STREET GROUP, LLC | 02/14/2025 | 41,868 | $22,404 | 48.99% | 0.11% |
| MARINER, LLC | 02/13/2025 | 35,000 | $18,729 | -13.65% | 0.09% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 29,552 | $16,000 | 100.00% | 0.08% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 20,785 | $11,122 | 0.00% | 0.05% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 17,355 | $11,280 | 0.00% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 4,008 | $2,144 | 2,078.26% | 0.01% |
| JPMORGAN CHASE & CO | 02/12/2025 | 911 | $487 | -0.33% | 0.00% |
| 02/06/2025 | 200 | $107 | 100.00% | 0.00% | |
| SALEM INVESTMENT COUNSELORS INC | 01/13/2025 | 40 | $22 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 1 | $1 | 100.00% | 0.00% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NEWTYN MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bolt Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 46 institutional investors and hedge funds held shares of Bolt Biotherapeutics, Inc.. The most heavily invested institutionals were:
TANG CAPITAL MANAGEMENT LLC: 3.81 M
Vivo Capital, LLC: 3.52 M
Sofinnova Investments, Inc.: 2.75 M
Pivotal bioVenture Partners Investment Advisor LLC: 1.89 M
Nan Fung Group Holdings Ltd: 1.17 M
VANGUARD GROUP INC: 1.07 M
48.81% of Bolt Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 19.45 M shares in the last 24 months. This purchase volume represents approximately $12.06 M in transactions.